Zi-ming Du
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Risk-adaptive therapy guided by dynamic ctDNA in nasopharyngeal carcinoma.
Journal: Nature
Published: July 30, 2025
Clinical and molecular characteristics of RNF43 mutations as promising prognostic biomarkers in colorectal cancer.
Journal: Therapeutic advances in medical oncology
Published: April 05, 2023
Monitoring tumour resistance to the BRAF inhibitor combination regimen in colorectal cancer patients via circulating tumour DNA.
Journal: Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy
Published: September 10, 2022
Targeted demethylation at ZNF154 promotor upregulates ZNF154 expression and inhibits the proliferation and migration of Esophageal Squamous Carcinoma cells.
Journal: Oncogene
Published: January 11, 2022
Smoking status combined with tumor mutational burden as a prognosis predictor for combination immune checkpoint inhibitor therapy in non-small cell lung cancer.
Journal: Cancer medicine
Published: June 16, 2021
The Prognostic Value of Locoregional Interventions for BRAF V600E Metastatic Colorectal Cancer: A Retrospective Cohort Analysis.
Journal: Biomolecules
Published: June 16, 2021
Diagnostic and Prognostic Characteristics of Circulating Free DNA Methylation Detected by the Electrochemical Method in Malignant Tumors.
Journal: Cancers
Published: January 05, 2021
Erratum to: Low expression of ULK1 is associated with operable breast cancer progression and is an adverse prognostic marker of survival for patients.
Journal: Breast cancer research and treatment
Published: March 11, 2016
Inhibition of MiR-155 suppresses cell migration in nasopharyngeal carcinoma through targeting ZDHHC2.
Journal: International journal of clinical and experimental medicine
Published: March 29, 2015
Last Updated: 09/26/2026